Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More Advocacy at a Glance STEVEN GROSSMAN 10/19/19 Advocacy at a Glance STEVEN GROSSMAN 10/19/19 Congress Returns; Appears No Closer to Reconciling House and Senate 302(b) Allocations or Solving Border Wall Funding Read More Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More Advocacy at a Glance STEVEN GROSSMAN 9/30/19 Advocacy at a Glance STEVEN GROSSMAN 9/30/19 President to Sign CR; Government Will Stay Open to November 21 Read More Analysis and Commentary STEVEN GROSSMAN 9/20/19 Analysis and Commentary STEVEN GROSSMAN 9/20/19 More Questions and More Answers ... Once Again Read More Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Senate Unveils Proposed $80 Million Increase for FDA Read More Analysis and Commentary STEVEN GROSSMAN 9/13/19 Analysis and Commentary STEVEN GROSSMAN 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Senate Appropriations to Mark-Up Ag/FDA Bill on Tuesday, September 17 Read More Analysis and Commentary STEVEN GROSSMAN 9/6/19 Analysis and Commentary STEVEN GROSSMAN 9/6/19 Much to Gain from a Smooth Appropriations Process Read More Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Congress Returns September 9/10 to Hectic Fall, Including Funding Bills Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More
Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More
Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/19/19 Advocacy at a Glance STEVEN GROSSMAN 10/19/19 Congress Returns; Appears No Closer to Reconciling House and Senate 302(b) Allocations or Solving Border Wall Funding Read More
Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More
Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More
Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More
Advocacy at a Glance STEVEN GROSSMAN 9/30/19 Advocacy at a Glance STEVEN GROSSMAN 9/30/19 President to Sign CR; Government Will Stay Open to November 21 Read More
Analysis and Commentary STEVEN GROSSMAN 9/20/19 Analysis and Commentary STEVEN GROSSMAN 9/20/19 More Questions and More Answers ... Once Again Read More
Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Senate Unveils Proposed $80 Million Increase for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 9/13/19 Analysis and Commentary STEVEN GROSSMAN 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More
Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Senate Appropriations to Mark-Up Ag/FDA Bill on Tuesday, September 17 Read More
Analysis and Commentary STEVEN GROSSMAN 9/6/19 Analysis and Commentary STEVEN GROSSMAN 9/6/19 Much to Gain from a Smooth Appropriations Process Read More
Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Congress Returns September 9/10 to Hectic Fall, Including Funding Bills Read More
